Analysis index

10 ml urine

See findings report

Suspicion of drug abuse, intoxication, abstinence checks

Simple drug screening (abbreviation: DRU1):

Test for cannabinoids, cocaine, benzoylecgonine, amphetamines, methamphetamines, MDA, MDMA, opiates, methadone or EDDP by immunoassay.

Standard drug screening (abbreviation DRU2):

Test for cannabinoids, cocaine, benzoylecgonine, amphetamines, methamphetamines, MDA, MDMA, opiates, methadone or EDDP by immunoassay as well as test for opiates, benzodiazepines via LC-MS/MS. When this test series is requested, we use a chromatographic method (LC-MS/MS) in addition to the immunological tests, especially for the differentiation of opiates (Morphine, 6-monoacetylmorphin, codeine, dihydrocodeine) and benzodiazepines (Diazepam, nordiazepam, oxazepam, bromazepam, flunitrazepam, 7-aminoflunitrazepam, lorazepam) as well as Z-substances (Zolpidem, zopiclone, zaleplon). This way you will receive knowledge about your patient’s drug consumption and concomitant consumption within the shortest amount of time and with only minimal analytical expenditure.

Drug- plus medication screening (abbreviation: DRU3):

As per DRU2 with additional testing for tricyclic antidepressants and medication (approximately 4000 substances).

Opioid screening (abbreviation: OPIOIU):

• Buprenorphine, norbuprenorphine, tilidin, nortilidin, oxycodone, tramadol, O-desmethyl tramadol, fentanyl, norfentanyl (LC-MS/MS)

Alcohol markers:

• Ethylglucuronid (EMIT/CEDIA), screening (abbreviation: ETHYUI)
• Ethylglucuronid (LC-MS/MS), confirmation analysis (abbreviation: ETHYLU)

Advantages of the screening methods (DRU1, DRU2, DRU3):

• Due to the lower limit values of immunoassay (ELISA/CEDIA/EMIT) as well as chromatography (LC-MS/MS), the detection time of most substances in the urine is increased.
• Opiates, benzodiazepines and opioids are analyzed chromatographically by means of LC-MS/MS. Because of this, it can be differentiated whether heroin, morphine, codeine or dihydrocodeine were consumed, as there is a difference between the detection of the opiates morphine, 6-monoacetylmorphinea, codeine and dihydrocodeine.
• Furthermore, the detection of EDDP is proof of oral methadone consumption.
• In case of benzodiazepines and opioids, clarification as to which substance is present in the urine, is obtained via LC-MS/MS analysis.
• As opiates, benzodiazepines and opioids are tested chromatographically by LC-MS/MS, results are admissible in court, if required.
• The overall analysis only takes a very short time, as a multitude of substances can be detected simultaneously in the urine with a single chromatographic test.

Confirmation analysis for quick screening test:

If desired, positive results from an immunochemical quick screening in the urine, obtained in your practice, can be confirmed from the leftover material with a chromatographic method.

Test for new psychoactive substances (NPS):

It is possible to demonstrate a large number of modern designer drugs such as synthetic cannabinoids and cathinones as well as tryptamine- and piperazine derivates in the urine with classical methods such as GC-MS as well as with new analytical methods, especially LC-MS/MS and Q-TOF. The spectrum of substances covered is continuously increased.